|
Volumn 25, Issue 1, 2005, Pages 85-88
|
Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: A placebo-controlled pilot study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
ANTIANDROGEN;
CITALOPRAM;
FLUTAMIDE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
BINGE EATING DISORDER;
BULIMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRY SKIN;
FEMALE;
HUMAN;
NAUSEA;
PILOT STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SYMPTOMATOLOGY;
ADULT;
ANDROGEN ANTAGONISTS;
BULIMIA;
CITALOPRAM;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUTAMIDE;
HUMANS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
SEROTONIN UPTAKE INHIBITORS;
TRANSAMINASES;
|
EID: 12344287791
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/01.jcp.0000150222.31007.a9 Document Type: Article |
Times cited : (52)
|
References (7)
|